HER-2/neu protein: A target for antigen-specific immunotherapy of human cancer

被引:153
作者
Disis, ML
Cheever, MA
机构
来源
ADVANCES IN CANCER RESEARCH, VOL 71 | 1997年 / 71卷
关键词
D O I
10.1016/S0065-230X(08)60103-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
引用
收藏
页码:343 / 371
页数:29
相关论文
共 106 条
[1]
ADAMS GP, 1993, CANCER RES, V53, P4026
[2]
Allison A C, 1994, Int J Technol Assess Health Care, V10, P107
[3]
ALLISON DE, 1996, FASEB J, V10, pA1338
[4]
HER-2/NEU IN NODE-NEGATIVE BREAST-CANCER - PROGNOSTIC-SIGNIFICANCE OF OVEREXPRESSION INFLUENCED BY THE PRESENCE OF INSITU CARCINOMA [J].
ALLRED, DC ;
CLARK, GM ;
TANDON, AK ;
MOLINA, R ;
TORMEY, DC ;
OSBORNE, CK ;
GILCHRIST, KW ;
MANSOUR, EG ;
ABELOFF, M ;
EUDEY, L ;
MCGUIRE, WL .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (04) :599-605
[5]
SYNTHETIC PEPTIDES AS VACCINES [J].
ARNON, R ;
HORWITZ, RJ .
CURRENT OPINION IN IMMUNOLOGY, 1992, 4 (04) :449-453
[6]
BACUS SS, 1992, CANCER RES, V52, P2580
[7]
THE NEU ONCOGENE ENCODES AN EPIDERMAL GROWTH-FACTOR RECEPTOR-RELATED PROTEIN [J].
BARGMANN, CI ;
HUNG, MC ;
WEINBERG, RA .
NATURE, 1986, 319 (6050) :226-230
[8]
Phase II study of weekly intravenous recombinant humanized Anti-p185(HER2) monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast [J].
Baselga, J ;
Tripathy, D ;
Mendelsohn, J ;
Baughman, S ;
Benz, CC ;
Dantis, L ;
Sklarin, NT ;
Seidman, AD ;
Hudis, CA ;
Moore, J ;
Rosen, PP ;
Twaddell, T ;
Henderson, IC ;
Norton, L .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) :737-744
[9]
BEERLI RR, 1994, J BIOL CHEM, V269, P23931
[10]
OVEREXPRESSION OF HER-2 NEU IN ENDOMETRIAL CANCER IS ASSOCIATED WITH ADVANCED STAGE DISEASE [J].
BERCHUCK, A ;
RODRIGUEZ, G ;
KINNEY, RB ;
SOPER, JT ;
DODGE, RK ;
CLARKEPEARSON, DL ;
BAST, RC .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 164 (01) :15-21